United States
Germany
Japan
United Kingdom
China
Anti-ERBB2 / HER2 / CD340 Reference Antibody (trastuzumab-MMAE)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Primary Antibodies
Anti-FOLR1 / FRA Reference Antibody (mirvetuximab-MMAE)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (margetuximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
Anti-FOLR1 / FRA Reference Antibody (farletuzumab-MMAE)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (trastuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Rat |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (BioMab patent anti-Her2)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (coprelotamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-CD59 Reference Antibody (Quark patent anti-CD59)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab emtansine)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Hersintuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-FOLR1 / FRA Reference Antibody (Dompe patent anti-FOLR1)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD74 Reference Antibody (milatuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Cynomolgus |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Anbenitamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (timigutuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
活动过滤器
优化搜索结果
Target Symbol
- AMH (30)
- PDCD1 / PD-1 / CD279 (29)
- ERBB1 / EGFR / HER1 (24)
- AMYLOID BETA (20)
- BNP (18)
- CD19 (18)
- CD4 (17)
- ERBB2 / HER2 / CD340 (16)
- B7-H1 / PD-L1 / CD274 (15)
- EGFR (15)
- MUC1 (15)
- PCSK9 (14)
- CD20 (13)
- CD40LG (13)
- TNFRSF5 / CD40 (12)
- CD52 (11)
- IL-6 / IFNB2 (11)
- TNFSF2 / TNFA (11)
- CD38 (10)
- CD3E (10)
- IL-13 (10)
- IL2RA (10)
- CTLA-8 / IL-17A (9)
- IGF1R / CD221 (9)
- SIGLEC-2 / CD22 (9)
- TNF (9)
- CCR5 (8)
- CD37 (8)
- CD47 (8)
- CLDN6 (8)
- HGFR / C-MET (8)
- CD40 (7)
- CEACAM5 / CEA / CD66E (7)
- COMPLEMENT C5 (7)
- ERBB2 (7)
- FOLR1 / FRA (7)
- ITGA2B (7)
- NGF / BNGF (7)
- SIGLEC-3 / CD33 (7)
- TNFRSF4 / OX40 / CD134 (7)
- AXL / UFO (6)
- CSF2 / GM-CSF (6)
- CTLA-4 / CD152 (6)
- ERBB3 / HER3 (6)
- GLUCOSE 6 PHOSPHATASE, CATALYTIC SUBUNIT (6)
- IL-6RA / CD126 (6)
- INSR (6)
- LAG3 / CD223 (6)
- MESOTHELIN (6)
- MSLN (6)
- TGFB1 (6)
- TNFRSF10B / TRAILR2 / CD262 (6)
- VEGFA (6)
- VEGFR2 / KDR / CD309 (6)
- CD28 (5)
- CD33 (5)
- CD74 (5)
- CD80 (5)
- IFNG (5)
- IGE (5)
- ITGA4 (5)
- ITGAL (5)
- MUC16 (5)
- PSCA (5)
- TAU (5)
- TIGIT (5)
- TROP2 (5)
- VEGF (5)
- ADRB2 (4)
- ALCAM / CD166 (4)
- ANGPT2 (4)
- AOC3 (4)
- B7-H3 / CD276 (4)
- C5AR1 (4)
- CD44 (4)
- CD53 (4)
- CD59 (4)
- CD63 (4)
- CD7 (4)
- CD79B (4)
- CD81 (4)
- CEA (4)
- CR1 (4)
- CSF1R / M-CSFR / CD115 (4)
- EPCAM (4)
- EPCAM / TROP1 / CD326 (4)
- EPHA2 (4)
- F3 / FACTOR III / TISSUE FACTOR / CD142 (4)
- FCER1G (4)
- FCRN (FCGRT & B2M) (4)
- FN1 (4)
- GDF8 / MYOSTATIN (4)
- HISTONE H2A.X (4)
- HSD17B13 (4)
- ICOS / CD278 (4)
- IFNA1 (4)
- IL-23 (4)
- IL-2RA / CD25 (4)
- IL-33 (4)
- IL18 (4)
Applications
Antibody Hosts
Expression Hosts
Conjugates
Isotypes
- IgG1 (786)
- IgG, kappa (267)
- IgG1, kappa (166)
- IgG4SP (100)
- IgG (87)
- IgG2SA (80)
- IgG2a, kappa (50)
- IgG4 (50)
- IgG2b, kappa (19)
- Fab fragment, kappa (17)
- IgG1, lambda (12)
- IgM, kappa (6)
- IgG2 (5)
- IgG3, kappa (4)
- IgG4PE (3)
- IgG2a, lambda (2)
- mIgG2 (2)
- IgG2a (1)
- IgG2b, lambda (1)
- IgG4P (1)
- V-kappa (1)
- mIgG1 (1)
- mIgG3 (1)
- scFv (1)
Clonalities
Mutants
Assay Types
Brands
Families
Pathways
- Cytokine-cytokine receptor interaction (30)
- TGF-beta signaling pathway (30)
- Insulin signaling pathway (8)
- Adipocytokine signaling pathway (6)
- Galactose metabolism (6)
- Glycolysis / Gluconeogenesis (6)
- Metabolic pathways (6)
- Starch and sucrose metabolism (6)
- Systemic lupus erythematosus (4)
- Acute myeloid leukemia (2)
- Bladder cancer (2)
- Chemokine signaling pathway (2)
- Chronic myeloid leukemia (2)
- Colorectal cancer (2)
- Endometrial cancer (2)
- ErbB signaling pathway (2)
- Focal adhesion (2)
- Glioma (2)
- Long-term depression (2)
- Long-term potentiation (2)
- MAPK signaling pathway (2)
- Melanoma (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Non-small cell lung cancer (2)
- Pancreatic cancer (2)
- Pathways in cancer (2)
- Progesterone-mediated oocyte maturation (2)
- Prostate cancer (2)
- Regulation of actin cytoskeleton (2)
- Renal cell carcinoma (2)
- Thyroid cancer (2)
- Vascular smooth muscle contraction (2)
- mTOR signaling pathway (2)
